Biolase (BIOL) Misses Q1 EPS by 4c

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.18), $0.04 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• SanDisk upgraded at JPMorgan after investor day; shares climb